BACKGROUND AND PURPOSEμ-Opioid receptors, pro-opiomelanocortin and pro-enkephalin are highly expressed in the nucleus tractus solitarii (NTS) and μ receptor agonists given to the NTS dose-dependently increased BP. However, the molecular mechanisms of this process remain unclear. In vitro, μ receptors heterodimerize with α2A-adrenoceptors. We hypothesized that α2A-adrenoceptor agonists would lose their depressor effects when their receptors heterodimerize in the NTS with μ receptors.
EXPERIMENTAL APPROACHWe microinjected μ-opioid agonists and antagonists into the NTS of rats and measured changes in BP. Formation of μ receptor/α2A-adrenoceptor heterodimers was assessed with immunofluorescence and co-immunoprecipitation methods, along with proximity ligation assays.
KEY RESULTSImmunofluorescence staining revealed colocalization of α2A-adrenoceptors and μ receptors in NTS neurons. Co-immunoprecipitation revealed interactions between α2A-adrenoceptors and μ receptors. In situ proximity ligation assays confirmed the presence of μ receptor/α2A-adrenoceptor heterodimers in the NTS. Higher levels of endogenous endomorphin-1 and μ receptor/α2A-adrenoceptor heterodimers were found in the NTS of hypertensive rats, than in normotensive rats. -ol]-enkephalin (DAMGO), but not that of the α2A-adrenoceptor agonist guanfacine, into the NTS of normotensive rats increased μ receptor/α2A-adrenoceptor heterodimer formation and BP elevation. The NO-dependent BP-lowering effect of α2A-adrenoceptor agonists was blunted following increased formation of μ receptor/α2A-adrenoceptor heterodimers in the NTS of hypertensive rats and DAMGO-treated normotensive rats.